시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 로사르탄 칼륨 원료의약품(API) 시장 보고서(2025년)
Losartan Potassium Active Pharmaceutical Ingredient (API) Global Market Report 2025
상품코드 : 1760599
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,217,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 8,987,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,756,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

로살탄 칼륨 원료의약품(API) 시장 규모는 향후 몇 년 동안 강력한 성장세를 보이며 2029년까지 6.9%의 연평균 성장률로 24억 4,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 만성질환을 앓고 있는 환자 인구의 증가, 심혈관계 예방 의료에 대한 관심 증가, 신흥 시장에서의 헬스케어 서비스 보급 확대, 제형 기술 발전, 제네릭 의약품을 장려하는 정부 이니셔티브의 증가 등의 요인에 기인하는 것으로 보입니다. 이 기간 동안 선진 패키징 트렌드에는 제조 공정의 발전, 첨단 약물전달 시스템 개발, 소아에 적합한 제형 개발, 유통기한 연장을 위한 패키징 기술 혁신, 로살탄을 포함한 병용요법 개발 등이 포함됩니다.

고혈압 유병률의 증가는 로살탄 칼륨 원료의약품(API) 시장의 성장을 촉진할 것으로 예상됩니다. 고혈압은 지속적인 고혈압을 특징으로 하는 질환으로 심장병, 뇌졸중 및 기타 심각한 건강 합병증의 위험을 증가시킵니다. 고혈압 발병률의 증가는 소금과 가공식품이 많은 식습관이 체액 저류와 심장의 부담을 증가시키는 주요 원인으로 작용합니다. 로살탄칼륨은 혈관을 수축시키는 호르몬인 안지오텐신 II를 억제하여 고혈압을 억제합니다. 혈관을 이완시키고 확장시킴으로써 로살탄 칼륨은 혈압을 낮추고 심장의 부담을 줄입니다. 예를 들어, 2024년 1월 미국심장협회는 2022년 주요 고혈압 관련 사망자 수가 13만 1,454명으로 2021년 12만 4,508명에서 증가했다고 보고했습니다. 결과적으로 고혈압 유병률의 증가는 로살탄 칼륨 API 시장의 성장에 박차를 가하고 있습니다.

로사르탄 칼륨 API 시장의 기업들은 로사르탄 칼륨 경구 현탁액과 같이 환자의 순응도와 투약 정확도를 높이는 혁신적인 제품 개발에 주력하고 있습니다. 이 액체 형태의 로살탄 칼륨은 정제를 삼키기 어려운 환자를 위해 설계되었습니다. 예를 들어, 2025년 3월 미국 바이오 제약사 사이언스 홀딩스(Science Holdings Inc.)는 고혈압 치료, 좌심실 비대증을 동반한 고혈압 환자의 뇌졸중 위험 감소, 제2형 당뇨병 환자의 당뇨병성 신증에 대한 적응증으로 즉시 사용 가능한 액상 제제인 Arbli의 FDA 승인을 획득했습니다. Arbli는 165mL의 페퍼민트 향이 나는 현탁액(10mg/mL)으로, 실온에서 18개월 동안 보관할 수 있으며, 배합제가 필요 없는 정확한 투약이 가능합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 거시경제 시나리오 : 금리·인플레이션·지정학·무역 전쟁·관세·코로나와 회복이 시장에 미치는 영향을 포함한다

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계 시장 : 경쟁 벤치마킹·대시보드

제33장 주요 기업 인수합병(M&A)

제34장 최근의 시장 동향

제35장 시장 잠재력 높은 나라·부문과 전략

제36장 부록

ksm
영문 목차

영문목차

Losartan potassium active pharmaceutical ingredient (API) refers to the pure compound used in the formulation of losartan-based medications, which are primarily used to treat high blood pressure and protect kidney function. It mainly helps manage hypertension, reduces the risk of heart attacks, and preserves kidney function in diabetic patients.

The main product forms of losartan potassium API include tablets, capsules, and others. Tablets are the most commonly used oral form, valued for their ease of use, affordability, and precise dosing in managing hypertension. It is produced through various methods such as synthetic routes, biotechnological processes, and continuous flow production. Distribution channels include online pharmacies, hospital pharmacies, retail pharmacies, and others. Losartan potassium is used for a range of conditions, including hypertension, heart failure, chronic kidney disease, and more. It is employed by various end-users, such as hospitals, clinics, home care settings, and pharmaceutical companies.

The losartan potassium API market research report is one of a series of new reports from The Business Research Company that provides losartan potassium API market statistics, including the losartan potassium API industry global market size, regional shares, competitors with the losartan potassium API market share, detailed losartan potassium API market segments, market trends, and opportunities, and any further data you may need to thrive in the losartan potassium API industry. This losartan potassium API market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The losartan potassium active pharmaceutical ingredient (API) market size has grown strongly in recent years. It will grow from $1.75 billion in 2024 to $1.87 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth during the historic period can be attributed to factors such as the growing adoption of antihypertensive drugs, the rising incidence of lifestyle-related disorders, increased awareness of cardiovascular health, higher global healthcare expenditure, and the growing demand for affordable generic medications.

The losartan potassium active pharmaceutical ingredient (API) market size is expected to see strong growth in the next few years. It will grow to $2.44 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth during the forecast period can be attributed to factors such as an expanding patient population with chronic illnesses, a growing emphasis on preventive cardiovascular care, increased healthcare service penetration in emerging markets, advancements in drug formulation technologies, and rising government initiatives to promote generic drugs. Key trends during this period include advancements in manufacturing processes, the development of advanced drug delivery systems, the creation of pediatric-friendly formulations, innovations in packaging for extended shelf life, and the development of combination therapies involving losartan.

The rising prevalence of hypertension is expected to drive the growth of the losartan potassium active pharmaceutical ingredient (API) market. Hypertension is a condition characterized by persistently high blood pressure, which increases the risk of heart disease, stroke, and other serious health complications. The growing incidence of hypertension is largely attributed to diets high in salt and processed foods, which contribute to fluid retention and increased strain on the heart. Losartan potassium helps control hypertension by blocking angiotensin II, a hormone that constricts blood vessels. By relaxing and widening blood vessels, losartan potassium lowers blood pressure and reduces the workload on the heart. For instance, in January 2024, the American Heart Association reported that 131,454 deaths were primarily linked to high blood pressure in 2022, a rise from 124,508 deaths in 2021. As a result, the increasing prevalence of hypertension is fueling the growth of the losartan potassium API market.

Companies in the losartan potassium API market are focusing on developing innovative products to enhance patient compliance and precision in dosing, such as losartan potassium oral suspension. This liquid form of losartan potassium is designed for patients who have difficulty swallowing tablets. For example, in March 2025, Scienture Holdings Inc., a US-based biopharmaceutical company, received FDA approval for Arbli, a ready-to-use liquid formulation for hypertension treatment, stroke risk reduction in hypertensive patients with left ventricular hypertrophy, and diabetic nephropathy in type 2 diabetes patients. Arbli offers precise dosing without the need for compounding and comes in a 165 mL peppermint-flavored suspension (10 mg/mL) with an 18-month shelf life at room temperature.

In April 2025, Scienture Holdings Inc., a US-based pharmaceutical company, formed a partnership with Saptalis Pharmaceuticals LLC to manufacture Arbli (losartan potassium) Oral Suspension, 10 mg/mL. The collaboration includes warehousing and distribution agreements to ensure market readiness for the first FDA-approved ready-to-use oral liquid losartan, addressing unmet needs in hypertension treatment. Saptalis Pharmaceuticals LLC, a US-based pharmaceutical company, specializes in developing and distributing losartan potassium formulations.

Major players in the losartan potassium active pharmaceutical ingredient (API) market are Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd, Dr. Reddy's Laboratories, Cadila Pharmaceuticals Ltd, Lupin Ltd, Zydus Lifesciences Ltd, Alkem Laboratories Ltd, IPCA Laboratories Ltd, Alembic Pharmaceuticals Ltd, Granules India Limited, Vasudha Pharma Chem Ltd, IOL Chemicals and Pharmaceuticals Limited, Unichem Laboratories Ltd, Global Pharma Tek, Hetero Drugs Ltd, Manus Aktteva Biopharma LLP, Wellona Pharma, Atom pharma, Sinoway Industrial Co. Ltd, Cerata Pharmaceuticals LLP.

North America was the largest region in the losartan potassium API market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in losartan potassium active pharmaceutical ingredient (API) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the losartan potassium active pharmaceutical ingredient (API) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The losartan potassium active pharmaceutical ingredient (API) market consists of sales of bulk powder, granules, injectable concentrates, and pre-formulated intermediates. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Losartan Potassium Active Pharmaceutical Ingredient (API) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on losartan potassium active pharmaceutical ingredient (api) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for losartan potassium active pharmaceutical ingredient (api) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The losartan potassium active pharmaceutical ingredient (api) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Losartan Potassium Active Pharmaceutical Ingredient (API) Market Characteristics

3. Losartan Potassium Active Pharmaceutical Ingredient (API) Market Trends And Strategies

4. Losartan Potassium Active Pharmaceutical Ingredient (API) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Losartan Potassium Active Pharmaceutical Ingredient (API) Growth Analysis And Strategic Analysis Framework

6. Losartan Potassium Active Pharmaceutical Ingredient (API) Market Segmentation

7. Losartan Potassium Active Pharmaceutical Ingredient (API) Market Regional And Country Analysis

8. Asia-Pacific Losartan Potassium Active Pharmaceutical Ingredient (API) Market

9. China Losartan Potassium Active Pharmaceutical Ingredient (API) Market

10. India Losartan Potassium Active Pharmaceutical Ingredient (API) Market

11. Japan Losartan Potassium Active Pharmaceutical Ingredient (API) Market

12. Australia Losartan Potassium Active Pharmaceutical Ingredient (API) Market

13. Indonesia Losartan Potassium Active Pharmaceutical Ingredient (API) Market

14. South Korea Losartan Potassium Active Pharmaceutical Ingredient (API) Market

15. Western Europe Losartan Potassium Active Pharmaceutical Ingredient (API) Market

16. UK Losartan Potassium Active Pharmaceutical Ingredient (API) Market

17. Germany Losartan Potassium Active Pharmaceutical Ingredient (API) Market

18. France Losartan Potassium Active Pharmaceutical Ingredient (API) Market

19. Italy Losartan Potassium Active Pharmaceutical Ingredient (API) Market

20. Spain Losartan Potassium Active Pharmaceutical Ingredient (API) Market

21. Eastern Europe Losartan Potassium Active Pharmaceutical Ingredient (API) Market

22. Russia Losartan Potassium Active Pharmaceutical Ingredient (API) Market

23. North America Losartan Potassium Active Pharmaceutical Ingredient (API) Market

24. USA Losartan Potassium Active Pharmaceutical Ingredient (API) Market

25. Canada Losartan Potassium Active Pharmaceutical Ingredient (API) Market

26. South America Losartan Potassium Active Pharmaceutical Ingredient (API) Market

27. Brazil Losartan Potassium Active Pharmaceutical Ingredient (API) Market

28. Middle East Losartan Potassium Active Pharmaceutical Ingredient (API) Market

29. Africa Losartan Potassium Active Pharmaceutical Ingredient (API) Market

30. Losartan Potassium Active Pharmaceutical Ingredient (API) Market Competitive Landscape And Company Profiles

31. Losartan Potassium Active Pharmaceutical Ingredient (API) Market Other Major And Innovative Companies

32. Global Losartan Potassium Active Pharmaceutical Ingredient (API) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Losartan Potassium Active Pharmaceutical Ingredient (API) Market

34. Recent Developments In The Losartan Potassium Active Pharmaceutical Ingredient (API) Market

35. Losartan Potassium Active Pharmaceutical Ingredient (API) Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기